On November 15, 2021, the 53rd world-renowned comprehensive medical exhibition MEDICA was grandly opened in Düsseldorf, Germany. As the world's largest hospital and medical equipment exhibition, MEDICA attracts exhibitors and visitors from all over the world to discuss and exchange the latest scientific research results in the medical industry. As a veteran exhibitor, Biolight brought many new products to participate in booth 9B54 in the main hall this time, becoming a Chinese enterprise that has attracted much attention.

This year's MEDICA, with the theme of " ILLUMINATING THE LIFE ", Biolight unveiled three product lines of life information and support, blood purification and family medical care, exploring the truth of medical science with the attitude of a light-seeker, climbing the peak of the industry with the power of extremely intelligent technology, and creating a light that illuminates life.

Among them, the new P series high-end monitors released by Biolight this year have become the focus of the audience.

With years of deep technical cultivation and continuous R&D and innovation, combined with clinical focus needs, Biolight has successfully launched the P series high-end monitor, bringing more convenient, smarter, more efficient and more accurate monitoring options to the clinic, which has been widely used in hospital ICUs, operating rooms and various intensive care units, helping more patients to ignite the light of life.

Under the guidance of the brand mission of "Houde Seiko, protect health", Biolight has always been responsible for saving people, and protecting the health of patients around the world is also the original intention of Biolight. In the golden age of manufacturing in China, Biolight has always adhered to the principle of "patient first" and "clinical priority", and all its work focuses on the design and operation of patient needs and good experience, providing valuable, innovative and high-quality products and services for patients around the world, so that the light of life shines on health.

Wu Xiaodong, head of overseas marketing of Biolight, who led the team on this expedition, said, "In the post-epidemic era, the world's demand for intelligent medical care and health monitoring is also different from the past, which requires us to adhere to the perspective of patients and clinics, and continue to develop products that are more in line with user needs and more humane, so that patients and medical staff can more easily deal with clinical problems." In the future, BLAITE will increase investment in research and development, continue to improve its competitiveness, launch more high-quality products and services, and contribute to the protection of the health of all mankind. ”